This has been a year like no other. Our lives were upended in the first quarter as the novel coronavirus spread to every corner of the globe. Universities and health centers shuttered, and researchers and clinicians found themselves grappling with tough new questions: Can my research or clinical trial continue remotely? What happens to my study participants or lab animals? How do I provide adequate telehealth services? And who is going to look after my children, home from school all day long?
The autism research community has been figuring it out — and generating a flurry of research that Spectrum staff have covered from their kitchen tables and comfiest chairs, thanks to video interviews, virtual conferences, drone photoshoots and endless Zoom sessions. Here are some of our 2020 highlights.
The Spectrum team highlights five topics that distinguished autism research in 2020: diversity in data, gene therapies, subtyping, social circuitry and the ‘autism gene’ debate.
Gene therapies and the factors influencing autism traits top Spectrum’s list of the 10 most notable research findings we covered in 2020.
Our staff picks the stories, podcasts and special reports that stood out from the rest this past year.
In our favorite quotes from stories we published in 2020, researchers contemplate blue poop, celebrate null findings and find a few silver linings in life during lockdown.
Feast your eyes on glowing glia and organoids; high-resolution, digital renditions of mouse brains; fluorescent beads passing through zebrafish guts and more.
Spectrum‘s staff couldn’t report on the ground this year — with no lab visits, sit-down interviews or in-person conferences to attend — but we observed a lot of changes from our computer screens.